We present the results of a set of experiments designed to measure the dispersion of non-spherical particles in a wave–current flow. We released negatively buoyant discs, rods and unit-aspect-ratio cylinders into a flow both with and without waves and analysed their respective landing positions to quantify how much they had dispersed while in the flow. We found that the presence of waves significantly increased the dispersion of the particles, and that the magnitude of this increase depends on particle shape and volume. In particular, thinner rods and thinner discs have greater relative dispersion than thicker rods and thicker discs, respectively, and smaller particles have greater relative dispersion than larger particles. Although the particles travelled farther in the presence of waves, the increase in dispersion was much greater than could be explained solely by increased transport distance. These results indicate that models of microplastic transport must account for waves as well as particle characteristics.

Background: Despite a higher prevalence of traumatic spinal cord injury (TSCI) amongst Canadian Indigenous peoples, there is a paucity of studies focused on Indigenous TSCI. We present the first Canada-wide study comparing TSCI amongst Canadian Indigenous and non-Indigenous peoples. Methods: This study is a retrospective analysis of prospectively-collected TSCI data from the Rick Hansen Spinal Cord Injury Registry (RHSCIR) from 2004-2019. We divided participants into Indigenous and non-Indigenous cohorts and compared them with respect to demographics, injury mechanism, level, severity, and outcomes. Results: Compared with non-Indigenous patients, Indigenous patients were younger, more female, less likely to have higher education, and less likely to be employed. The mechanism of injury was more likely due to assault or transportation-related trauma in the Indigenous group. The length of stay for Indigenous patients was longer. Indigenous patients were more likely to be discharged to a rural setting, less likely to be discharged home, and more likely to be unemployed following injury. Conclusions: Our results suggest that more resources need to be dedicated for transitioning Indigenous patients sustaining a TSCI to community living and for supporting these patients in their home communities. A focus on resources and infrastructure for Indigenous patients by engagement with Indigenous communities is needed.

Radiocarbon dating of marine samples requires a local marine reservoir correction, or ΔR value, for accurate age calibrations. For the Samoan Archipelago in the central Pacific, ΔR values have been proposed previously, but, unlike some Polynesian archipelagoes, ΔR values seem not to vary spatially and temporally. Here, we demonstrate such variability by reporting a ΔR of –101±72 ΔR for the Manu‘a Group—the eastern-most islands in the archipelago—for the colonization period. This value is based on accelerator mass spectrometry (AMS) 14C and uranium-thorium (U-Th) series dating of individual coral branches from pre-2300 cal BP archaeological contexts. This figure differs from the previously proposed modern ΔR of 28±26 yr derived from dated historic, pre-1950, shell samples from the western islands of Samoa. Consequently, we recommend using the ΔR of –101±72 yr for the 1st millennium BC in Manu‘a, and 28±26 yr for calibrating dates within the 2nd millennium AD in the western islands (Savai‘i to Tutuila). Until more data from across the archipelago and from throughout the entire culture-historical sequence document ΔR variability, we recommend that researchers use both of these ΔR values to evaluate how the dates of marine-derived samples compare with AMS dates on identified, short-lived wood charcoal.

On June 13, 2012, a group of key stakeholders, leaders, and national experts on tuberculosis (TB), occupational health, and laboratory science met in Atlanta, Georgia, to focus national discussion on the higher than expected positive results occurring among low-risk, unexposed healthcare workers undergoing serial testing with interferon-γ release assays (IGRAs). The objectives of the meeting were to present the latest clinical and operational research findings on the topic, to discuss evaluation and treatment algorithms that are emerging in the absence of national guidance, and to develop a consensus on the action steps needed to assist programs and physicians in the interpretation of serial testing IGRA results. This report summarizes its proceedings.